Charles J. Casamento's most recent trade in Eton Pharmaceuticals Inc was a trade of 12,196 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 12,196 | 295,171 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 7,757 | 302,928 | - | - | Restricted Stock Units | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 164,000 | 164,000 | - | - | Stock Appreciation Rights | |
| GT Biopharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 62,500 | 62,500 | - | - | Option to purchase Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Eton Pharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Oct 2024 | 13,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Purchase of securities on an exchange or from another person at price $ 2.56 per share. | 09 Sep 2024 | 13,000 | 13,000 (0%) | 0% | 2.6 | 33,280 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Other type of transaction at price $ 0.00 per share. | 24 May 2024 | 20,976 | 31,522 | - | - | Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,976 | 52,498 | - | - | Stock Option (right to buy) | |
| PaxMedica Inc | Charles J. Casamento | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 12 Mar 2024 | 992 | 2,386 | - | 0.7 | 684 | Common Stock |
| Eton Pharma Inc | Charles Casamento J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 30,000 | 164,555 | - | - | Stock Option (Right to buy) | |
| PaxMedica Inc | Casamento Charles J. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. | 29 Jan 2024 | 97 | 3,378 | - | 0.8 | 74 | Common Stock |
| First Wave BioPharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 19,633 | 19,937 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Casamento Charles J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 31,522 | 31,522 | - | - | Stock Option (right to buy) | |
| GT Biopharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 500,000 | 500,000 | - | - | Option to purchase Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 92,958 | 150,000 | - | - | Stock Option (right to buy) | |
| PaxMedica Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2023 | 14,000 | 65,583 | - | 0 | Common Stock | |
| Eton Pharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 25,000 | 134,555 | - | - | Stock Option (Right to buy) | |
| First Wave BioPharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 84,745 | 85,134 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 57,042 | 57,042 | - | - | Stock Option (right to buy) | |
| PaxMedica Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 51,583 | 51,583 | - | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.24 per share. | 01 Apr 2022 | 19,800 | 19,800 (0%) | 0% | 3.2 | 64,152 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 19,800 | 77,511 | - | - | Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 3,300 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 6,600 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 9,900 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 13,200 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 16,500 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 0 (0%) | 0% | 29 | 95,700 | Common Stock |
| Eton Pharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 50,000 | 109,555 | - | - | Stock Option (Right to buy) | |
| First Wave BioPharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 58,765 | 58,765 | - | - | Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.60 per share. | 22 Sep 2021 | 10,000 | 16,600 (0%) | 0% | 4.6 | 46,000 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 22 Sep 2021 | 3,300 | 11,400 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 22 Sep 2021 | 1,900 | 14,700 (0%) | 0% | 29 | 55,100 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2021 | 1,900 | 97,311 | - | - | Options to purchase common stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 22 Sep 2021 | 1,400 | 10,000 (0%) | 0% | 29 | 40,600 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 10,000 | 102,500 | - | - | Options to purchase common stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.60 per share. | 17 Aug 2021 | 10,000 | 14,700 (0%) | 0% | 4.6 | 46,000 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 15 Jul 2021 | 2,136 | 5,854 (0%) | 0% | 31.0 | 66,272 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 15 Jul 2021 | 1,164 | 4,700 (0%) | 0% | 32.5 | 37,816 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 33.19 per share. | 01 Jun 2021 | 2,480 | 6,950 (0%) | 0% | 33.2 | 82,300 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 01 Jun 2021 | 520 | 9,430 (0%) | 0% | 34.1 | 17,721 | Common Stock |